Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Australia
Market Movers: September Grain Stocks Report
What does potential inflation build mean for the grain markets?
Market Movers: FOMC Meeting
Will the Fed reaffirm their hawkish tone at next week's FOMC meeting? (Sponsored)
Striking Options: Tariffs, Equities, Rates
Why is the S&P 500 taking the latest round of tariffs in stride?
David Axelrod: How The Election Map Will Play A Role in Midterms
"More than several" suburban swing districts could shift the balance to Democrats this fall, says former Obama adviser. (Sponsored)
Market Movers: Central Bank Meetings
Will the ECB and BOE maintain their interest rate path?
Striking Options: NASDAQ, FX, and Equities
Stronger-than-expected jobs data along with heightened trade concerns over U.S.-China is giving boost to the U.S. dollar.
This Company Is at the Center of Insider Trading Charges Against Rep. Collins
Innate Immunotherapeutics of Australia is the biopharmaceutical company at the center of the insider trading charges leveled against New York Rep. Chris Collins.
Schlumberger Gains as International Outlook Offsets In-Line Results
The company is looking favorably upon international markets in the coming months as the turnaround of the drilling industry starts to take hold.
Bitcoin Today: Prices Dip as Regulatory Bodies Weigh In
Bitcoin cedes earlier gains by Tuesday afternoon. Here's what you need to know.
Mesoblast Soars on Stem-Cell Treatment Data
The Australian company unveiled data from a study evaluating a potential treatment for children with steroid refractory acute Graft Versus Host Disease.